-
BG Medicine; ACS Biomarker; Cardiovascular Research Institute Maastricht; Medrad; Bayer HealthCare; Possis Medical; Merit Medical Systems; Micrus Endovascular; Mindray Medical International; Datascope; Nfocus Neuromedical; Acta Vascular Systems
-
Full prescription coverage of heart drugs could help heart attack survivors live longer and lower the nation's healthcare costs, according to an analysis reported in Circulation: Journal of the American Heart Association.
-
Advanced Cell Technology; Cordis; Angiotech Pharmaceuticals; Rex Medical; Aporo Biomedical; mNemoscience; Cardiac Science; CH2M HILL; Cummins Engine; Colubris Networks; Cardiac Science; Premier Purchasing Partners; Atrium Medical; W.L. Gore & Associates
-
As the saying goes, sometimes no decision is a decision, and such was the case in last week's announcement by the Centers for Medicare & Medicaid Services to make no change to its current payment policy for computerized tomography for angiography (CTA).
-
Biophan Technologies; CryoCath Technologies; Edwards Lifesciences; ev3; Naviscan PET Systems; NewCardio; Omron Healthcare; Spectranetics
-
Dr. Rolf Kaese, chief executive of Berlin Heart (Berlin), is resigning from the company, citing strategy differences with Syscore (London), which acquired the company in October 2006.
-
Abbot Laboratories (Abbott Park, Illinois) treceived CE mark approval for a 2.25 mm version of its XIENCE V Everolimus Eluting Coronary Stent System, offering a smaller stent for a wider range of stent sizes for treating a variety of patient types.
-
-
Stem Cell Therapeutics (SCT; Calgary, Alberta) at this year's Stroke meeting reported favorable results from its Beta-hCG + Erythropoietin in Acute Stroke (BETAS) Phase IIa, open label, safety trial conducted at the University of California, Irvine and Hoag Presbyterian Memorial Hospital (Newport Beach, California).
-
A team of researchers at Oregon Health & Science University (OHUSU; Eugene) and Washington University (St. Louis) say they have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered and patented with potential to become a breakthrough drug for treating heart attacks and strokes.
